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Compatibility of 5-ethynyl-2’F-ANA UTP with in vitro selection for 
the generation of base-modified, nuclease resistant aptamers
Fabienne Levi-Acobas,a,b‡ Adam Katolik,c,d‡ Pascal Röthlisberger,a,b Thomas Cokelaer,e,f Ivo 
Sarac,a,b Masad J. Damha,d Christian J. Leumann,c and Marcel Hollensteina,b*
 
A modified nucleoside triphosphate bearing two modifications 
based on a 2’-deoxy-2’-fluoro-arabinofuranose sugar and a uracil 
nucleobase equipped with a C5-ethynyl moiety (5-ethynyl-2’F-ANA 
UTP) was synthesized. This nucleotide analog could enzymatically 
be incorporated into DNA oligonucleotides by primer extension and 
reverse transcribed to unmodified DNA. . This nucleotide could be 
used in SELEX for the identification of high binding affinity and 
nuclease resistant aptamers. 
Xeno nucleic acids (XNAs) are analogs of the two natural genetic 
polymers (DNA and RNA) bearing modifications at the level of 
the sugar.1-4 The presence of these chemical modifications 
provides XNAs with properties that are absent or muted in 
corresponding natural systems. For instance, the presence of 
sugar modifications markedly improves the nuclease resistance 
of oligonucleotides which is of highly relevant for therapeutic5-
9 and in vivo applications.10, 11 Similarly, base-modifications 
convey orthogonality to modified nucleic acids12-19 and provide 
functionalities to synthetic genetic polymers, which improve 
their catalytic20-22 and/or binding capacities.23-25 The synthesis 
of XNAs proceeds either via a chemical route (using 
phosphoramidites during automated solid-phase synthesis) or a 
chemoenzymatic method, whereby a polymerase incorporates 
modified nucleotides.26, 27 The latter method endows some 
advantages compared to solid phase synthesis, including: 1) 
high functional group tolerance; 2) unrestricted oligonucleotide 
length; and 3) compatibility with SELEX and related 
combinatorial in vitro selection methods. Combined with recent 
progress in polymerase engineering28 these intrinsic properties 
have instigated the selection of numerous XNA aptamers29-37 
and catalysts.38-40 However, the modification pattern of most 
XNA nucleotide analogues is restricted to a single location of the 
nucleosidic scaffold. To date, only a few reports have shown the 
possibility of introducing two simultaneous modifications in 
XNAs, all concerning threose nucleic acid (TNA) nucleotides32, 41, 
42. Here, we report the synthesis and biochemical 
characterization of a 2’-deoxy-2’F-arabinonucleic acid (2’F-ANA) 
uridine analog decorated with an ethynyl group on the 
nucleobase. We clearly demonstrate the compatibility of this 
XZA nucleotide (modification of the sugar (X instead of D) and 
the nucleobase (Z instead of N))4 with a full replication cycle (i.e. 
DNA-dependent synthesis of modified DNA followed by 
reverse-transcription to wild-type DNA) and thus with SELEX 
methods. Finally, we also demonstrate the usefulness of the 
ethynyl moiety as a synthetic handle for the further 
modification of XNA polymers. 
The 2’F-ANA modification is known to increase the affinity of 
DNA for complementary RNA, is a DNA mimic (South/East sugar 
pucker) and increases the nuclease resistance of 
oligonucleotides,43-46 thus it is worthwhile to pursue. Moreover, 
the 2’F-ANA scaffold is clearly compatible with SELEX since 2’F-
ANA 5’-triphosphates are substrates for DNA polymerases,47, 48 
and recently, potent catalysts38, 39 and aptamers30, 31 were 
isolated. The 5-ethynyl-dUTP (EdUTP) base modification is a 
widely used nucleotide analog.24, 49 It is well tolerated by 
polymerases in vitro and in vivo,50-52 and the alkyne moiety 
represents a convenient synthetic handle to incorporate 
additional modifications by applying click chemistry (copper(I)-
catalyzed alkyne–azide cycloaddition or CuAAC).53 
Synthesis of the modified nucleotide started with the 
bromination of the anomeric center of the commercially 
available nucleoside 1 (Scheme 1). The presence of the 2’-
fluorine ensures that the bromine atom is installed in the α 
configuration in compound 2. The expected South pucker of 
arabinose places the halogens at C1’ and C2’ in pseudoaxial 
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positions, which are stabilized by gauche (O4’-C1’-C2’-F2’) and 
anomeric effects (O4’-C1’-Br), respectively.54 The modified 
nucleobase was then installed on the sugar moiety by 
application of modified Vorbrüggen conditions.55, 56 This 
reaction is always in competition with the analogous SN1 
reaction, which forms a mixture of both anomers. The 
contribution of SN1 and SN2 depends mostly on the solvent and 
the temperature, and generally the combination of low solvent 
polarity and elevated temperature renders acceptable results. 
We therefore chose toluene and 80°C overnight reflux as 
reaction conditions (see Supporting Information) and both 
anomers were formed (1:10 α/β), which could be separated by 
chromatography yielding compound 3 in moderate yields. 
Removal of the blocking groups of 3 was followed by 5’-DMTr 
protection yielding 5 in good yields (57% over two steps). 
Acetylation and detritylation of nucleoside 5 led to the suitably 
3’-O-protected nucleoside 7, which was subjected to Ludwig-
Eckstein conditions57 to generate the desired 5’-triphosphate 8. 
The low yields obtained during this last step stem from a rather 
lengthy purification protocol and highlight the need for more 
robust and generally applicable protocols for the synthesis of 
nucleoside triphosphate analogs.58
Scheme 1. Synthesis of 5-ethynyl-2’F-ANA UTP 8. Reagents and conditions: i) 
HBr/AcOH, 0°C to rt, 12 h; ii) 5-(2-trimethylsilylethynyl)-uracil, BSA, toluene, 80°C, 
12h, 42% (over 2 steps); iii) a) NaOH in THF/MeOH/H2O (5:4:1), 0°C, 1h; b) NH4Cl, 
rt, 20 min, 69%; iv) DMTrCl, pyridine, rt, 12 h, 83%; v) Ac2O, pyridine, 0°C to rt, 1h, 
80%; vi) TFA, CH2Cl2, 0°C to rt, 30 min, 45%; vii) a) 2-chloro-1,3,2-
benzodioxaphosphorin-4-one, pyridine, dioxane, rt, 45 min; b) (nBu3NH)2H2P2O7, 
DMF, nBu3N, rt, 45 min; c) I2, pyridine, H2O, rt, 30 min; d) NH3(aq.), rt, 1.5 h, 2% (4 
steps).
With 5-ethynyl-2’F-ANA UTP 8 at hand, we proceeded to 
evaluate the capacity of polymerases to incorporate this 
modified nucleotide into DNA. To do so, primer extension (PEX) 
reactions were carried out with various polymerases 
(Therminator, Vent (exo-), Bst, Deep Vent, the Klenow fragment 
of DNA polymerase I exo- (Kf exo-), and Taq) and by using 
triphosphate 8 instead of its natural counterpart dTTP. The 
possibility of incorporating nucleotide 8 was first evaluated 
using the 37-nucleotide long template T1 and the 5’-FAM-
labelled, 21-mer primer P1 (see Table S1 for the sequence 
compositions). With the exception of Bst, all polymerases led to 
the full conversion of primers to the expected full-length 
products with minimal truncated sequences (Figure S1). Next, 
we evaluated the possibility of incorporating multiple, 
consecutive modifications. To this end, we applied template T2, 
which contains seven adenine nucleotides located immediately 
5’-downstream to the 3’-end of primer P2.59 In this context, 
Vent (exo-) polymerase managed to incorporate six modified 
nucleotides while Therminator produced full length products 
accompanied by some non-templated addition (Figure S2).60 
Moreover, Deep Vent, Taq, and Kf exo- also incorporated the 
modified nucleotide albeit less efficiently, while Bst did not 
incorporate any modified nucleotide. A similar preference for 
family B over family A polymerases was observed previously 
with unmodified 2’F-ANA-nucleotides, suggesting that the 
ethynyl moiety has a negligible impact on the incorporation 
efficiency.47, 48 Surprisingly, nucleotide 8 is a rather poor 
substrate for polymerases under PCR conditions since only 
Therminator led to amplified full-length products albeit in lower 
yields compared to the control reaction performed with natural 
dNTPs (Figure S4). 
Having identified conditions, which enable the polymerization 
of the modified nucleotide, we wanted to ascertain that the 
ethynyl moiety, once installed in 2’F-ANA-modified 
oligonucleotides, the ethynyl moiety was still accessible to 
further chemical modification by the CuAAC reaction. Thus, PEX 
reactions were carried out with the T3/P3 system. The resulting 
products were then incubated with an azide-modified biotin 
derivative (obtained by amide coupling of biotin with 2-
azidoethanamine61) under click reaction conditions (see 
Supporting Information). Next, the biotin-modified, 5-ethynyl-
2’F-ANA -containing oligonucleotides were incubated with 
avidin and analyzed using gel electrophoresis.42 Figure 1 clearly 
shows that biotinylated avidin treated 2’F-ANA-
oligonucleotides from Therminator PEX reactions are unable to 
enter the gel due to the presence of the protein (lane 8). A 
similar trend can be observed when using Vent (exo-) as a 
polymerase, albeit in lower yields (lane 7). 
Figure 1. Gel analysis (PAGE 20%) of the functionalization of 2ˈF-ANA-
oligonucleotides by the CuAAC reaction. PEX reactions were carried out with the 
31-mer long template T3 and the 15-mer primer P3 leading to oligonucleotides 
containing four 5-ethynyl-2’F-ANA nucleotides. Lanes 1: PEX reactions with 
natural dNTPs and Taq polymerase; lanes 2: T4 DNA polymerase; lanes 3: Kf exo-; 
lanes 4: Bst; lanes 5: Taq polymerase; lanes 6: Deep Vent; lanes 7: Vent (exo-); 
lanes 8: Therminator. 
Lastly, to show applicability for SELEX experiments, it was 































3 R = H 4










R = DMTr 6


























































































Journal Name  COMMUNICATION
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3
Please do not adjust margins
Please do not adjust margins
not encounter misincorporation events; and 2) sequences 
containing 5-ethynyl-2’F-ANA-U modifications could be reverse-
transcribed back to unmodified DNA. To do so, first, the PEX 
reactions proceeded with a 98-nucleotide long template T4 and 
a 25-mer primer P4 (Figure S3).60 Next, -exonuclease was 
applied to digest and remove the unmodified template strand 
and the modified strand served as a template for DNA synthesis 
under PCR conditions (Figure 2A). Of the different polymerases 
tested, Q5 DNA polymerase led to strong amplification of the 
modified template. The resulting dsDNA product was then 
introduced into a library, which was subjected to Illumina 
sequencing (see Supporting Information). Data processing 
involved phix removal, mapping the data on the sense strand, 
and analysing the concordance (Figure 2B) as well as the 
number of errors per read (Figure S4). This analysis showed that 
99.2% of the reads have a concordance > 95% and that 95% of 
all reads have 2 or less errors with no detectable single 
nucleotide variants (SNVs) in any of the reads.62 Lastly, the very 
low rate of base substitution (<0.5%) further confirms the high 
fidelity of the DNA-modified DNA-DNA cycle.
Figure 2. A) Gel analysis (agarose 2%) of reverse-transcription reactions using a 98 
nucleotide long FANA-modified template and natural dNTPs. Lane 1: Phusion DNA 
polymerase and modified template; lane 2: Q5 DNA polymerase and modified template; 
lane 3: KOD XL DNA polymerase and modified template; lane 4: Taq DNA polymerase and 
unmodified DNA template; lane 5: Taq DNA polymerase, unmodified DNA template, and 
only three natural dNTPs (dATP, dCTP, dGTP). L represents a DNA weight ladder. B) 
Concordance of all the reads mapped to the Q5 DNA polymerase; concordance is defined 
as 1 - (D+I+M) / (D+M+I+S) where D, I, S and M stands for deletion, insertion, substitution 
and match, respectively)
Conclusions
In this report, we produced an XZA nucleoside triphosphate 
bearing two modifications consisting of a 2’F-ANA-sugar moiety 
and a C5-modified nucleobase. We also highlighted its 
compatibility with enzymatic synthesis of modified DNA and the 
possibility of using the ethynyl anchor for the introduction of 
additional functional groups. Lastly, sequencing and data 
analysis revealed the fidelity of incorporating the modified 
nucleotide into DNA and the efficiency of the conversion of 2’F-
ANA-containing oligonucleotides  back to DNA. The efficiency of 
5-ethynyl-2’F-ANA-synthesis might be further improved by 
using engineered polymerases31 and the sequencing protocol 
simplified by application of nanopore sequencing.63 Work 
towards these aims as well as application of the click-SELEX 
protocol24, 64 to identify aptamers featuring high binding affinity 
and nuclease resistance is currently ongoing. 
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Text to accompany our TOC graphic image:
A nucleoside triphosphate bearing modifications at both the sugar and the nucleobase level  was shown to be 
compatible with enzymatic synthesis and the CuAAC reaction and thus could be used to identify aptamers 
featuring high binding affinity and nuclease resistance.
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